Barclays’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.12M | Buy |
241,844
+31,490
| +15% | +$164K | ﹤0.01% | 2693 |
|
|
2025
Q4 | $1.05M | Buy |
210,354
+7,373
| +4% | +$38.4K | ﹤0.01% | 3396 |
|
|
2025
Q3 | $1.03M | Sell |
202,981
-240,698
| -54% | -$1.06M | ﹤0.01% | 3350 |
|
|
2025
Q2 | $1.91M | Buy |
443,679
+125,734
| +40% | +$621K | ﹤0.01% | 2883 |
|
|
2025
Q1 | $1.92M | Sell |
317,945
-29,677
| -9% | -$150K | ﹤0.01% | 2665 |
|
|
2024
Q4 | $1.37M | Sell |
347,622
-225,596
| -39% | -$1.01M | ﹤0.01% | 3169 |
|
|
2024
Q3 | $3.35M | Buy |
573,218
+204,956
| +56% | +$1.01M | ﹤0.01% | 2426 |
|
|
2024
Q2 | $1.59M | Sell |
368,262
-279,009
| -43% | -$1.34M | ﹤0.01% | 2301 |
|
|
2024
Q1 | $3.04M | Sell |
647,271
-1,339,217
| -67% | -$5.13M | ﹤0.01% | 2218 |
|
|
2023
Q4 | $9.75M | Buy |
1,986,488
+735,204
| +59% | +$3.6M | ﹤0.01% | 1536 |
|
|
2023
Q3 | $6.82M | Sell |
1,251,284
-1,398,020
| -53% | -$11.2M | ﹤0.01% | 1151 |
|
|
2023
Q2 | $24.5M | Buy |
2,649,304
+873,061
| +49% | +$7.38M | 0.02% | 653 |
|
|
2023
Q1 | $14.6M | Sell |
1,776,243
-248,938
| -12% | -$2.75M | 0.01% | 988 |
|
|
2022
Q4 | $22.6M | Buy |
2,025,181
+379,215
| +23% | +$4.41M | 0.01% | 832 |
|
|
2022
Q3 | $19.5M | Sell |
1,645,966
-1,513,347
| -48% | -$22.9M | 0.02% | 612 |
|
|
2022
Q2 | $48.2M | Buy |
3,159,313
+794,225
| +34% | +$14.3M | 0.03% | 413 |
|
|
2022
Q1 | $50M | Buy |
2,365,088
+989,984
| +72% | +$21.3M | 0.04% | 407 |
|
|
2021
Q4 | $32.5M | Buy |
1,375,104
+266,100
| +24% | +$5.7M | 0.01% | 740 |
|
|
2021
Q3 | $22.3M | Sell |
1,109,004
-93,547
| -8% | -$1.92M | 0.01% | 837 |
|
|
2021
Q2 | $24.2M | Buy |
1,202,551
+39,609
| +3% | +$847K | 0.01% | 800 |
|
|
2021
Q1 | $24.7M | Buy |
1,162,942
+430,922
| +59% | +$9.27M | 0.01% | 714 |
|
|
2020
Q4 | $15.9M | Buy |
732,020
+412,421
| +129% | +$8.04M | 0.01% | 937 |
|
|
2020
Q3 | $5.63M | Sell |
319,599
-219,578
| -41% | -$4.09M | ﹤0.01% | 1328 |
|
|
2020
Q2 | $10.1M | Sell |
539,177
-32,814
| -6% | -$581K | 0.01% | 951 |
|
|
2020
Q1 | $9.89M | Sell |
571,991
-355,862
| -38% | -$7.44M | 0.01% | 995 |
|
|
2019
Q4 | $19.6M | Buy |
927,853
+719,646
| +346% | +$14.6M | 0.01% | 964 |
|
|
2019
Q3 | $4.07M | Sell |
208,207
-678,558
| -77% | -$12.5M | ﹤0.01% | 2036 |
|
|
2019
Q2 | $15.5M | Sell |
886,765
-20,804
| -2% | -$375K | 0.01% | 1083 |
|
|
2019
Q1 | $16.8M | Buy |
907,569
+817,789
| +911% | +$14.6M | 0.01% | 945 |
|
|
2018
Q4 | $1.44M | Sell |
89,780
-104,961
| -54% | -$1.66M | ﹤0.01% | 2740 |
|
|
2018
Q3 | $2.9M | Buy |
194,741
+26,822
| +16% | +$391K | ﹤0.01% | 2451 |
|
|
2018
Q2 | $2.36M | Buy |
167,919
+117,150
| +231% | +$1.55M | ﹤0.01% | 2418 |
|
|
2018
Q1 | $660K | Buy |
50,769
+15,921
| +46% | +$204K | ﹤0.01% | 3670 |
|
|
2017
Q4 | $482K | Buy |
34,848
+144
| +0.4% | +$1.95K | ﹤0.01% | 3871 |
|
|
2017
Q3 | $455K | Sell |
34,704
-329,748
| -90% | -$4.25M | ﹤0.01% | 3714 |
|
|
2017
Q2 | $4.69M | Buy |
364,452
+310,085
| +570% | +$4.13M | 0.01% | 1518 |
|
|
2017
Q1 | $698K | Buy |
54,367
+19,199
| +55% | +$245K | ﹤0.01% | 3071 |
|
|
2016
Q4 | $433K | Buy |
35,168
+4,814
| +16% | +$62.3K | ﹤0.01% | 3498 |
|
|
2016
Q3 | $448K | Buy |
30,354
+8,258
| +37% | +$125K | ﹤0.01% | 3323 |
|
|
2016
Q2 | $336K | Sell |
22,096
-890
| -4% | -$12.6K | ﹤0.01% | 3539 |
|
|
2016
Q1 | $276K | Sell |
22,986
-21,642
| -48% | -$247K | ﹤0.01% | 3616 |
|
|
2015
Q4 | $491K | Buy |
44,628
+23,887
| +115% | +$273K | ﹤0.01% | 3234 |
|
|
2015
Q3 | $228K | Sell |
20,741
-52,770
| -72% | -$655K | ﹤0.01% | 4047 |
|
|
2015
Q2 | $956K | Buy |
73,511
+60,490
| +465% | +$844K | ﹤0.01% | 2922 |
|
|
2015
Q1 | $182K | Buy |
13,021
+2,662
| +26% | +$39.5K | ﹤0.01% | 4417 |
|
|
2014
Q4 | $135K | Buy |
10,359
+3,742
| +57% | +$50.1K | ﹤0.01% | 4951 |
|
|
2014
Q3 | $79K | Sell |
6,617
-122,630
| -95% | -$1.63M | ﹤0.01% | 5517 |
|
|
2014
Q2 | $1.68M | Buy |
129,247
+73,519
| +132% | +$976K | ﹤0.01% | 2785 |
|
|
2014
Q1 | $669K | Sell |
55,728
-981,867
| -95% | -$12.6M | ﹤0.01% | 3665 |
|
|
2013
Q4 | $12.5M | Buy |
1,037,595
+914,838
| +745% | +$11.7M | 0.01% | 1091 |
|
|
2013
Q3 | $1.47M | Sell |
122,757
-23,747
| -16% | -$317K | ﹤0.01% | 2923 |
|
|
2013
Q2 | $2.1M | Buy |
+146,504
| New | +$2.31M | ﹤0.01% | 2498 |
|
Other funds holding MPT
VPM
VCM
WAM
Barclays's MPT Position: Q1 2026 in Review
Barclays increased its Medical Properties Trust (MPT) stake by 15% in Q1 2026, buying an estimated $164K and bringing the position to 241,844 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.
Barclays first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $50M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- Barclays held 241,844 shares of Medical Properties Trust worth $1.12M as of Q1 2026.
- Barclays bought 31,490 Medical Properties Trust shares in Q1 2026, an estimated $164K.
- Medical Properties Trust made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2693 holding.
- Barclays first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
- Barclays's Medical Properties Trust position peaked at $50M in Q1 2022.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.